Cardiovascular Clinical Trial - AMGEN - 890 Olpasiran
Cardiovascular
Status:
Open to accrualClinicalTrials.gov:
NCT04270760OlpasiranĀ Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study
OlpasiranĀ Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study